Side effects like reactions at the injection site are common
Capacity (milliamps - amp hours)
Common side effects include nausea, constipation, diarrhea, reflux, bloating, reduced appetite, and abdominal discomfort
For combination therapy (CagriSema), the cagrilintide component is 2.4 mg weekly paired with semaglutide 2.4 mg
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure N Engl J Med
The most common early side effects nausea, appetite suppression, fatigue, and gastrointestinal discomfort peak within the first day or two after injection and taper across the week